Information identifying certain issuers has been excluded from this exhibit because it is both not material and is the type that the Reporting Persons treat as private or confidential. Accession Agreement between dievini Hopp BioTech holding GmbH &...Dievini Hopp BioTech Holding GmbH & Co KG • February 22nd, 2022 • Pharmaceutical preparations
Pool Agreement on the pooling of shares in CureVac N.V. between dievini Hopp BioTech holding GmbH & Co. KG, Johann-Jakob-Astor-Str. 57, 69190 Walldorf, Germany - hereinafter referred to as “dievini” - and DH-LT-Investments GmbH, Opelstrasse 28, 68789...Pool Agreement • February 22nd, 2022 • Dievini Hopp BioTech Holding GmbH & Co KG • Pharmaceutical preparations
JOINT FILING STATEMENTJoint Filing Statement • February 22nd, 2022 • Dievini Hopp BioTech Holding GmbH & Co KG • Pharmaceutical preparations
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the common shares of CureVac N.V. and further agree that this Joint Filing Agreement be included as an exhibit to such joint filing.
